• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

提高放射基因组学的性能和通用性:一项利用多中心数据预测胶质瘤中异柠檬酸脱氢酶1/2(IDH1/2)突变状态的初步研究。

Improving performance and generalizability in radiogenomics: a pilot study for prediction of IDH1/2 mutation status in gliomas with multicentric data.

作者信息

Santinha João, Matos Celso, Figueiredo Mário, Papanikolaou Nikolaos

机构信息

Clinical Computational Imaging Group, Champalimaud Research, Champalimaud Foundation, Lisboa, Portugal.

Universidade de Lisboa, Instituto de Telecomunicações, Instituto Superior Técnico, Lisboa, Portugal.

出版信息

J Med Imaging (Bellingham). 2021 May;8(3):031905. doi: 10.1117/1.JMI.8.3.031905. Epub 2021 Apr 29.

DOI:10.1117/1.JMI.8.3.031905
PMID:33937440
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8082292/
Abstract

Radiogenomics offers a potential virtual and noninvasive biopsy. However, radiogenomics models often suffer from generalizability issues, which cause a performance degradation on unseen data. In MRI, differences in the sequence parameters, manufacturers, and scanners make this generalizability issue worse. Such image acquisition information may be used to define different environments and select robust and invariant radiomic features associated with the clinical outcome that should be included in radiomics/radiogenomics models. We assessed 77 low-grade gliomas and glioblastomas multiform patients publicly available in TCGA and TCIA. Radiomics features were extracted from multiparametric MRI images (T1-weighted, contrast-enhanced T1-weighted, T2-weighted, and fluid-attenuated inversion recovery) and different regions-of-interest (enhancing tumor, nonenhancing tumor/necrosis, and edema). A method developed to find variables that are part of causal structures was used for feature selection and compared with an embedded feature selection approach commonly used in radiomics/radiogenomics studies, across two different scenarios: (1) leaving data from a center as an independent held-out test set and tuning the model with the data from the remaining centers and (2) use stratified partitioning to obtain the training and the held-out test sets. In scenario (1), the performance of the proposed methodology and the traditional embedded method was AUC: 0.75 [0.25; 1.00] versus 0.83 [0.50; 1.00], Sens.: 0.67 [0.20; 0.93] versus 0.67 [0.20; 0.93], Spec.: 0.75 [0.30; 0.95] versus 0.75 [0.30; 0.95], and MCC: 0.42 [0.19; 0.68] versus 0.42 [0.19; 0.68] for center 1 as the held-out test set. The performance of both methods for center 2 as the held-out test set was AUC: 0.64 [0.36; 0.91] versus 0.55 [0.27; 0.82], Sens.: 0.00 [0.00; 0.73] versus 0.00 [0.00; 0.73], Spec.: 0.82 [0.52; 0.94] versus 0.91 [0.62; 0.98], and MCC: versus , whereas for center 3 was AUC: 0.80 [0.62; 0.95] versus 0.89 [0.56; 0.96], Sens.: 0.86 [0.48; 0.97] versus 0.86 [0.48; 0.97], Spec.: 0.72 [0.54; 0.85] versus 0.79 [0.61; 0.90], and MCC: 0.47 [0.41; 0.53] versus 0.55 [0.48; 0.60]. For center 4, the performance of both methods was AUC: 0.77 [0.51; 1.00] versus 0.75 [0.47; 0.97], Sens.: 0.53 [0.30; 0.75] versus 0.00 [0.00; 0.15], Spec.: 0.71 [0.35; 0.91] versus 0.86 [0.48; 0.97], and MCC: 0.23 [0.16; 0.31] versus. . In scenario (2), the performance of these methods was AUC: 0.89 [0.71; 1.00] versus 0.79 [0.58; 0.94], Sens.: 0.86 [0.80; 0.92] versus 0.43 [0.15; 0.74], Spec.: 0.87 [0.62; 0.96] versus 0.87 [0.62; 0.96], and MCC: 0.70 [0.60; 0.77] versus 0.33 [0.24; 0.42]. This proof-of-concept study demonstrated good performance by the proposed feature selection method in the majority of the studied scenarios, as it promotes robustness of features included in the models and the models' generalizability by making used imaging data of different scanners or with sequence parameters.

摘要

放射基因组学提供了一种潜在的虚拟无创活检方法。然而,放射基因组学模型常常存在泛化性问题,这会导致在未见数据上的性能下降。在磁共振成像(MRI)中,序列参数、制造商和扫描仪的差异使这个泛化性问题更加严重。此类图像采集信息可用于定义不同的环境,并选择与临床结果相关的稳健且不变的放射组学特征,这些特征应纳入放射组学/放射基因组学模型。我们评估了公开可用的来自癌症基因组图谱(TCGA)和癌症成像存档(TCIA)的77例低级别胶质瘤和多形性胶质母细胞瘤患者。从多参数MRI图像(T1加权、对比增强T1加权、T2加权和液体衰减反转恢复序列)以及不同的感兴趣区域(强化肿瘤、非强化肿瘤/坏死和水肿)中提取放射组学特征。一种用于寻找作为因果结构一部分的变量的方法被用于特征选择,并与放射组学/放射基因组学研究中常用的嵌入式特征选择方法进行比较,涵盖两种不同情况:(1)将来自一个中心的数据留作独立的验证测试集,并使用其余中心的数据对模型进行调优;(2)使用分层划分来获得训练集和验证测试集。在情况(1)中,将中心1的数据留作验证测试集时,所提出方法和传统嵌入式方法的性能为:曲线下面积(AUC):0.75 [0.25; 1.00] 对比 0.83 [0.50; 1.00],灵敏度(Sens.):0.67 [0.20; 0.93] 对比 0.67 [0.20; 0.93],特异度(Spec.):0.75 [0.30; 0.95] 对比 0.75 [0.30; 0.95],马修斯相关系数(MCC):0.42 [0.19; 0.68] 对比 0.42 [0.19; 0.68]。将中心2的数据留作验证测试集时,两种方法的性能为:AUC:0.64 [0.36; 0.91] 对比 0.55 [0.27; 0.82],Sens.:0.00 [0.00; 0.73] 对比 0.00 [0.00; 0.73],Spec.:0.82 [0.52; 0.94] 对比 0.91 [0.62; 0.98],MCC:[此处原文缺失部分内容] 对比 [此处原文缺失部分内容];而对于中心3,性能为:AUC:0.80 [0.62; 0.95] 对比 0.89 [0.56; 0.96],Sens.:0.86 [0.48; 0.97] 对比 0.86 [0.48; 0.97],Spec.:0.72 [0.54; 0.85] 对比 0.79 [0.61; 0.90],MCC:0.47 [0.41; 0.53] 对比 0.55 [0.48; 0.60]。对于中心4,两种方法的性能为:AUC:0.77 [0.51; 1.00] 对比 0.75 [0.47; 0.97],Sens.:0.53 [0.30; 0.75] 对比 0.00 [0.00; 0.15],Spec.:0.71 [0.35; 0.91] 对比 0.86 [0.48; 0.97],MCC:0.23 [0.16; 0.31] 对比 [此处原文缺失部分内容]。在情况(2)中,这些方法的性能为:AUC:0.89 [0.71; 1.00] 对比 0.79 [0.58; 0.94],Sens.:0.86 [0.80; 0.92] 对比 0.43 [0.15; 0.74],Spec.:0.87 [0.62; 0.96] 对比 0.87 [0.62; 0.96],MCC:0.70 [0.60; 0.77] 对比 0.33 [0.24; 0.42]。这项概念验证研究表明,在所研究的大多数情况下,所提出的特征选择方法具有良好的性能,因为它通过利用不同扫描仪或具有不同序列参数的成像数据,提高了模型中所包含特征的稳健性以及模型的泛化性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b972/8082292/0212e22a9de2/JMI-008-031905-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b972/8082292/659bd52e5b11/JMI-008-031905-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b972/8082292/e0c9632ea534/JMI-008-031905-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b972/8082292/7f4482504ec8/JMI-008-031905-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b972/8082292/c6821c3ab5f6/JMI-008-031905-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b972/8082292/29d9a6dd86b1/JMI-008-031905-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b972/8082292/a3fc37de31f2/JMI-008-031905-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b972/8082292/0212e22a9de2/JMI-008-031905-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b972/8082292/659bd52e5b11/JMI-008-031905-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b972/8082292/e0c9632ea534/JMI-008-031905-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b972/8082292/7f4482504ec8/JMI-008-031905-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b972/8082292/c6821c3ab5f6/JMI-008-031905-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b972/8082292/29d9a6dd86b1/JMI-008-031905-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b972/8082292/a3fc37de31f2/JMI-008-031905-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b972/8082292/0212e22a9de2/JMI-008-031905-g007.jpg

相似文献

1
Improving performance and generalizability in radiogenomics: a pilot study for prediction of IDH1/2 mutation status in gliomas with multicentric data.提高放射基因组学的性能和通用性:一项利用多中心数据预测胶质瘤中异柠檬酸脱氢酶1/2(IDH1/2)突变状态的初步研究。
J Med Imaging (Bellingham). 2021 May;8(3):031905. doi: 10.1117/1.JMI.8.3.031905. Epub 2021 Apr 29.
2
Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.使用多模态成像和机器学习算法的下一代放射基因组学测序预测非小细胞肺癌患者的EGFR和KRAS突变状态
Mol Imaging Biol. 2020 Aug;22(4):1132-1148. doi: 10.1007/s11307-020-01487-8.
3
Utilizing Radiomics of Peri-Lesional Edema in T2-FLAIR Subtraction Digital Images to Distinguish High-Grade Glial Tumors From Brain Metastasis.利用T2-FLAIR减影数字图像中瘤周水肿的影像组学特征鉴别高级别胶质瘤与脑转移瘤
J Magn Reson Imaging. 2025 Apr;61(4):1728-1737. doi: 10.1002/jmri.29572. Epub 2024 Sep 10.
4
Radiomics MRI Phenotyping with Machine Learning to Predict the Grade of Lower-Grade Gliomas: A Study Focused on Nonenhancing Tumors.基于机器学习的放射组学 MRI 表型预测低级别胶质瘤分级:一项聚焦于非增强肿瘤的研究。
Korean J Radiol. 2019 Sep;20(9):1381-1389. doi: 10.3348/kjr.2018.0814.
5
Noninvasive Prediction of IDH1 Mutation and ATRX Expression Loss in Low-Grade Gliomas Using Multiparametric MR Radiomic Features.使用多参数磁共振放射组学特征无创预测低级别胶质瘤中的 IDH1 突变和 ATRX 表达缺失。
J Magn Reson Imaging. 2019 Mar;49(3):808-817. doi: 10.1002/jmri.26240. Epub 2018 Sep 8.
6
MRI Radiomic Features to Predict IDH1 Mutation Status in Gliomas: A Machine Learning Approach using Gradient Tree Boosting.MRI 放射组学特征预测脑胶质瘤 IDH1 突变状态:基于梯度提升决策树的机器学习方法。
Int J Mol Sci. 2020 Oct 27;21(21):8004. doi: 10.3390/ijms21218004.
7
Machine Learning-Based Multiparametric Magnetic Resonance Imaging Radiomics for Prediction of H3K27M Mutation in Midline Gliomas.基于机器学习的多参数磁共振成像放射组学预测脑桥中线胶质瘤 H3K27M 突变。
World Neurosurg. 2021 Jul;151:e78-e85. doi: 10.1016/j.wneu.2021.03.135. Epub 2021 Apr 2.
8
Standardization of brain MR images across machines and protocols: bridging the gap for MRI-based radiomics.脑磁共振图像在机器和协议间的标准化:基于 MRI 的放射组学的桥梁。
Sci Rep. 2020 Jul 23;10(1):12340. doi: 10.1038/s41598-020-69298-z.
9
Improving radiomic model reliability using robust features from perturbations for head-and-neck carcinoma.利用头颈癌扰动的稳健特征提高放射组学模型的可靠性
Front Oncol. 2022 Oct 14;12:974467. doi: 10.3389/fonc.2022.974467. eCollection 2022.
10
Multiregional radiomics profiling from multiparametric MRI: Identifying an imaging predictor of IDH1 mutation status in glioblastoma.多参数 MRI 的多区域放射组学特征分析:在胶质母细胞瘤中发现 IDH1 突变状态的影像学预测指标。
Cancer Med. 2018 Dec;7(12):5999-6009. doi: 10.1002/cam4.1863. Epub 2018 Nov 13.

引用本文的文献

1
Bias in artificial intelligence for medical imaging: fundamentals, detection, avoidance, mitigation, challenges, ethics, and prospects.医学成像人工智能中的偏差:基础、检测、避免、缓解、挑战、伦理及前景
Diagn Interv Radiol. 2025 Mar 3;31(2):75-88. doi: 10.4274/dir.2024.242854. Epub 2024 Jul 2.
2
Development of End-to-End AI-Based MRI Image Analysis System for Predicting IDH Mutation Status of Patients with Gliomas: Multicentric Validation.端到端基于人工智能的 MRI 图像分析系统用于预测脑胶质瘤患者 IDH 突变状态的开发:多中心验证。
J Imaging Inform Med. 2024 Feb;37(1):31-44. doi: 10.1007/s10278-023-00918-6. Epub 2024 Jan 12.
3

本文引用的文献

1
Causality matters in medical imaging.医学影像学中因果关系很重要。
Nat Commun. 2020 Jul 22;11(1):3673. doi: 10.1038/s41467-020-17478-w.
2
Machine learning assisted DSC-MRI radiomics as a tool for glioma classification by grade and mutation status.机器学习辅助 DSC-MRI 放射组学作为一种基于分级和突变状态对胶质瘤进行分类的工具。
BMC Med Inform Decis Mak. 2020 Jul 6;20(1):149. doi: 10.1186/s12911-020-01163-5.
3
Overall survival prediction in glioblastoma patients using structural magnetic resonance imaging (MRI): advanced radiomic features may compensate for lack of advanced MRI modalities.
Accuracy of Radiomics in Predicting Mutation Status in Diffuse Gliomas: A Bivariate Meta-Analysis.
基于双变量 Meta 分析的影像组学预测弥漫性胶质瘤突变状态的准确性研究。
Radiol Artif Intell. 2024 Jan;6(1):e220257. doi: 10.1148/ryai.220257.
4
Investigating the value of radiomics stemming from DSC quantitative biomarkers in IDH mutation prediction in gliomas.研究源自DSC定量生物标志物的影像组学在胶质瘤IDH突变预测中的价值。
Front Neurol. 2023 Nov 16;14:1249452. doi: 10.3389/fneur.2023.1249452. eCollection 2023.
5
Artificial intelligence-driven radiomics study in cancer: the role of feature engineering and modeling.人工智能驱动的癌症放射组学研究:特征工程和建模的作用。
Mil Med Res. 2023 May 16;10(1):22. doi: 10.1186/s40779-023-00458-8.
6
Predicting IDH Mutation Status in Low-Grade Gliomas Based on Optimal Radiomic Features Combined with Multi-Sequence Magnetic Resonance Imaging.基于最优影像组学特征联合多序列磁共振成像预测低级别胶质瘤的异柠檬酸脱氢酶(IDH)突变状态
Diagnostics (Basel). 2022 Nov 30;12(12):2995. doi: 10.3390/diagnostics12122995.
7
Radiomics/Radiogenomics in Lung Cancer: Basic Principles and Initial Clinical Results.肺癌中的放射组学/放射基因组学:基本原理与初步临床结果
Cancers (Basel). 2022 Mar 25;14(7):1657. doi: 10.3390/cancers14071657.
利用结构磁共振成像(MRI)预测胶质母细胞瘤患者的总生存期:高级影像组学特征可能弥补高级MRI模式的不足。
J Med Imaging (Bellingham). 2020 May;7(3):031505. doi: 10.1117/1.JMI.7.3.031505. Epub 2020 Jun 9.
4
The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation.马修斯相关系数(MCC)在二分类评估中优于 F1 得分和准确率的优势。
BMC Genomics. 2020 Jan 2;21(1):6. doi: 10.1186/s12864-019-6413-7.
5
Gray-level discretization impacts reproducible MRI radiomics texture features.灰度离散化影响可重现的 MRI 放射组学纹理特征。
PLoS One. 2019 Mar 7;14(3):e0213459. doi: 10.1371/journal.pone.0213459. eCollection 2019.
6
Radiomics-based machine learning methods for isocitrate dehydrogenase genotype prediction of diffuse gliomas.基于放射组学的机器学习方法预测弥漫性脑胶质瘤异柠檬酸脱氢酶基因型。
J Cancer Res Clin Oncol. 2019 Mar;145(3):543-550. doi: 10.1007/s00432-018-2787-1. Epub 2019 Feb 4.
7
Multiregional radiomics profiling from multiparametric MRI: Identifying an imaging predictor of IDH1 mutation status in glioblastoma.多参数 MRI 的多区域放射组学特征分析:在胶质母细胞瘤中发现 IDH1 突变状态的影像学预测指标。
Cancer Med. 2018 Dec;7(12):5999-6009. doi: 10.1002/cam4.1863. Epub 2018 Nov 13.
8
Lesion location implemented magnetic resonance imaging radiomics for predicting IDH and TERT promoter mutations in grade II/III gliomas.病变部位磁共振成像组学预测 IDH 和 TERT 启动子突变在 II/III 级胶质瘤中的应用。
Sci Rep. 2018 Aug 6;8(1):11773. doi: 10.1038/s41598-018-30273-4.
9
Radiomics Strategy for Molecular Subtype Stratification of Lower-Grade Glioma: Detecting IDH and TP53 Mutations Based on Multimodal MRI.基于多模态 MRI 的 IDH 和 TP53 突变检测:低级别胶质瘤分子亚型分层的放射组学策略。
J Magn Reson Imaging. 2018 Oct;48(4):916-926. doi: 10.1002/jmri.25960. Epub 2018 Feb 2.
10
Computational Radiomics System to Decode the Radiographic Phenotype.用于解码影像学表型的计算放射组学系统
Cancer Res. 2017 Nov 1;77(21):e104-e107. doi: 10.1158/0008-5472.CAN-17-0339.